Table 7. Multivariable meta-regression analysis for different variables as indicated and described in the Methods section.
Potential Explanation Factor Variable | Resection Rate | Exploration Rate | CR | PR | SD | PD | Toxicity | Morbidity | Mortality |
Institution | 16.7% (17.4%) | 13.3% (15.0%) | 30.2% (31.9%) | 20.9% (16.7%) | 27.2% (10.7%) | 12.8% (24.9%) | 34.8% (35.2%) | 20.8% (14.3%) | 22.5% (19.6%) |
Study design | 1.2% (2.9%) | 0.6% (1.6%) | 3.1% (1.0%) | 10.7% (4.0%) | 4.1% (1.8%) | 3.6% (6.9%) | 3.8% (4.6%) | 8.7% (2.0%) | 2.3% (1.6%) |
Chemotherapy | 2.1% (3.1%) | 0.8% (1.6%) | 0.6% (8.1%) | 6.0% (7.2%) | 1.6% (0.8%) | 0.2% (0.4%) | 10.4% (2.4%) | 0.1% (0.5%) | 3.1% (6.8%) |
Mean year of study interval (decades) | 2.0% (1.9%) | 1.1% (0.2%) | 0.2% (2.0%) | 0.6% (6.7%) | 2.3% (1.0%) | 0.9% (7.0%) | 2.2% (1.5%) | 3.2% (2.0%) | 10.4% (10.6%) |
Mean patient age (5-y intervals) | 1.1% (1.1%) | 1.2% (0.6%) | 2.7% (1.1%) | 3.4% (3.4%) | 1.5% (1.8%) | 1.4% (1.7%) | 3.5% (2.6%) | 9.9% (4.1%) | 9.9% (4.6%) |
Response evaluation criteria | 1.5% (3.4%) | 2.7% (3.6%) | 2.4% (0.1%) | 2.6% (0.3%) | |||||
Resectability | 14.0% (9.0%) | 25.5% (10.5%) | 1.0% (0.9%) | 0.0% (2.6%) | 4.1% (0.9%) | 1.1% (8.1%) | 0.3% (0.2%) | 2.2% (4.9%) | 0.6% (0.2%) |
Resectability evaluation criteria | 0.1% (0.7%) | 1.4% (0.7%) |
The fraction of explained variance is given in %. Values in parentheses represent the fraction of explained variance in % from univariable analysis.
CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.